O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1.
暂无分享,去创建一个
[1] H. Jun,et al. Recent advances in insulin gene therapy for type 1 diabetes. , 2002, Trends in molecular medicine.
[2] K. Webster,et al. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. , 1998, Biochemical and biophysical research communications.
[3] U. Francke,et al. Molecular characterization of two mammalian bHLH-PAS domain proteins selectively expressed in the central nervous system. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] O. Pascual,et al. Ventilatory and central neurochemical reorganisation of O2 chemoreflex after carotid sinus nerve transection in rat , 2000, The Journal of physiology.
[5] S. McKnight,et al. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. , 1997, Genes & development.
[6] Nigel Mackman,et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress , 2000, Nature Medicine.
[7] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[8] G. Semenza,et al. Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[9] J. Levasseur,et al. Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. , 2002, American journal of physiology. Heart and circulatory physiology.
[10] M. Ivan,et al. HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.
[11] G. Semenza,et al. Role of hypoxia‐inducible factor‐1 in hypoxia‐induced ischemic tolerance in neonatal rat brain , 2000, Annals of neurology.
[12] P. Lewczuk,et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] G. Semenza,et al. Purification and Characterization of Hypoxia-inducible Factor 1 (*) , 1995, The Journal of Biological Chemistry.
[14] H. Forster,et al. Recovery of peripheral chemoreceptor function after denervation in ponies. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.
[15] D. Katayose,et al. Acute ischaemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischaemia. , 1994, Cardiovascular research.
[16] Jessica Lo,et al. HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .
[17] M. Gassmann,et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.
[18] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[19] E. Morishita,et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death , 1996, Neuroscience.
[20] Michael I. Wilson,et al. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.
[21] R. Ekman,et al. Pulmonary vascular pressure effects by endothelin-1 in normoxia and chronic hypoxia: a longitudinal study. , 1996, The American journal of physiology.
[22] S. Oparil,et al. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. , 1995, The American journal of physiology.
[23] D. Peet,et al. Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.
[24] Till Acker,et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.
[25] P. Carmeliet,et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.
[26] R. Hammer,et al. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. , 1998, Genes & development.
[27] P Ghezzi,et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Semenza,et al. Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia‐Reperfusion Injury , 2003, Circulation.
[29] P. Carmeliet,et al. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. , 2003, The Journal of clinical investigation.
[30] A. Bauer,et al. Regulation of tyrosine hydroxylase promoter activity by the von Hippel–Lindau tumor suppressor protein and hypoxia‐inducible transcription factors , 2003, Journal of neurochemistry.
[31] R. L. Martin-Body,et al. Restoration of hypoxic respiratory responses in the awake rat after carotid body denervation by sinus nerve section. , 1986, The Journal of physiology.
[32] S. Oparil,et al. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. , 1995, Journal of applied physiology.
[33] Y Fujii-Kuriyama,et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Oparil,et al. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. , 1994, Journal of applied physiology.
[35] S. White,et al. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] Y. Zou,et al. Nuclear Factor Interleukin 6 Motifs Mediate Tissue-specific Gene Transcription in Hypoxia* , 1997, The Journal of Biological Chemistry.
[37] J. Calbet. Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans , 2003, The Journal of physiology.
[38] R. Jennings,et al. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.
[39] N. Prabhakar. Oxygen sensing by the carotid body chemoreceptors. , 2000, Journal of applied physiology.
[40] J. Hogenesch,et al. Characterization of a Subset of the Basic-Helix-Loop-Helix-PAS Superfamily That Interacts with Components of the Dioxin Signaling Pathway* , 1997, The Journal of Biological Chemistry.
[41] G. Semenza,et al. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. , 1999, Developmental biology.
[42] G. Semenza,et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[43] P. Lewczuk,et al. Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial , 2002, Molecular medicine.
[44] I. Benjamin,et al. Protective responses in the ischemic myocardium. , 2000, The Journal of clinical investigation.
[45] J. Peng,et al. The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[46] Y. Zou,et al. Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration. , 2000, Journal of applied physiology.
[47] G. Semenza,et al. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.
[48] E. Baker,et al. Tolerance of the developing heart to ischemia: impact of hypoxemia from birth. , 1995, The American journal of physiology.
[49] Pietro Ghezzi,et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] W. Risau,et al. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels , 1997, Mechanisms of Development.
[51] G. Semenza,et al. HIF-1 and tumor progression: pathophysiology and therapeutics. , 2002, Trends in molecular medicine.
[52] G. Semenza,et al. Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] G. Semenza. Angiogenesis in ischemic and neoplastic disorders. , 2003, Annual review of medicine.
[54] T. Beaty,et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. , 1999, The Journal of clinical investigation.